Human reticulocyte-derived exosomes could be used as a novel vaccine platform against vivax malaria.
Credit
del Portillo et al.
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.